WALTHAM, Mass., May 23, 2008 (BUSINESS WIRE) -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, has been named by the Software & Information Industry Association (SIIA) as the winner of the 2008 CODiE Award for Best Medical and Health Information Product for its InForm(TM) Integrated Trial Management (ITM) 4.6 product.

Successfully used in more than 2,300 trials, the InForm electronic data capture (EDC) solution delivers end-to-end electronic clinical data management (eCDM) capabilities to sponsors and sites that rely on the capture, management and evaluation of collected clinical trial data.

The CODiE Awards, now in their 23rd year, use both journalist and peer-company reviews to identify the leaders and innovators in categories across the software, digital content and education technology industries. This year's winners were chosen from more than 1,100 nominations submitted by more than 600 companies for the excellence of their products, services, corporate leadership and philanthropy.

"The 2008 CODiE Awards recognize those companies providing the best new technology products and services across a broad array of industries," noted SIIA President Ken Wasch. "The awards and their winners are a testament to the power of technology to deliver innovative solutions to American businesses and consumers. SIIA congratulates all of the CODiE Award winners and nominees, whose innovation is essential for continuing America's leadership in the global knowledge economy."

"We are gratified by the recognition offered by SIIA," said Bob Weiler, CEO and president, Phase Forward. "We are pleased to accept this award on behalf of our customers, whose use of InForm reflects their commitment to leveraging technological innovation to bring drugs to market more safely and efficiently, and also our employees, whose dedication and commitment are clearly reflected in the product."

Winners were announced on May 20 at the CODiE Awards Gala at the Palace Hotel in San Francisco, CA. For a complete listing of all the award winners, visit: http://www.siia.net/codies/2008/finalists.asp.

About SIIA

The Software & Information Industry Association (SIIA) is the principal trade association for the software and digital content industry. SIIA provides global services in government relations, business development, corporate education and intellectual property protection to more than 800 leading software and information companies. For further information, visit www.siia.net.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm(TM)), phase I clinic automation (LabPas(TM)), clinical data management (Clintrial(TM)), clinical trials signal detection (CTSD(TM)), strategic pharmacovigilance (WebVDME(TM) and Signal Management), adverse event reporting (Empirica(TM) Trace) and applied data standards (WebSDM(TM)). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.

Cautionary Statement

Certain statements made in this press release that are not based on historical information are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This press release contains express or implied forward-looking statements relating to, among other things, the performance of Phase Forward's products and services, continued market acceptance of Phase Forward's products and services, and the ability of Phase Forward's customers to realize benefits from the use of Phase Forward's products and services. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond Phase Forward's control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things, the ability of Phase Forward's customers to realize benefits from the use of its products and services, the possibility that customers' needs or plans may change over time, and the introduction or improvement of products and services competitive with those of Phase Forward. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Phase Forward undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For additional disclosure regarding these and other risks faced by Phase Forward, see the disclosure contained in Phase Forward's public filings with the Securities and Exchange Commission including, without limitation, its most recent Annual Report on Form 10-K.